Current Portfolio
Tenpoint Therapeutics
Tenpoint Therapeutics is a clinical stage biopharmaceutical company, is launching a new era in presbyopia treatment and developing an innovative pipeline targeting the largest areas of unmet need for rejuvenating vision in the aging eye.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP 6
- Entry
2021
- EQT Responsible Advisor
John de Koning
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.